Crawford & Company® (NYSE: CRD-A and CRD-B), is pleased to announce its financial results for the third quarter ended ...
(Reuters) -Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue in a cash-and-stock deal valued at about $48.7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback